These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 19536326

  • 1. DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.
    Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AM.
    PLoS Med; 2009 May 26; 6(5):e1000068. PubMed ID: 19536326
    [Abstract] [Full Text] [Related]

  • 2. DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.
    Chen N, Balasenthil S, Reuther J, Frayna A, Wang Y, Chandler DS, Abruzzo LV, Rashid A, Rodriguez J, Lozano G, Cao Y, Lokken E, Chen J, Frazier ML, Sahin AA, Wistuba II, Sen S, Lott ST, Killary AM.
    Cancer Discov; 2013 Oct 26; 3(10):1172-89. PubMed ID: 23838884
    [Abstract] [Full Text] [Related]

  • 3. DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity.
    Chen N, Balasenthil S, Reuther J, Killary AM.
    Cancer Res; 2014 Oct 15; 74(20):5683-9. PubMed ID: 25261235
    [Abstract] [Full Text] [Related]

  • 4. Tumor suppressor DEAR1 regulates mammary epithelial cell fate and predicts early onset and metastasis in triple negative breast cancer.
    Le UQ, Chen N, Balasenthil S, Lurie E, Yang F, Liu S, Rubin L, Solis Soto LM, Raso MG, Batra H, Sahin AA, Wistuba II, Killary AM.
    Sci Rep; 2022 Nov 14; 12(1):19504. PubMed ID: 36376460
    [Abstract] [Full Text] [Related]

  • 5. Harnessing 3D models of mammary epithelial morphogenesis: An off the beaten path approach to identify candidate biomarkers of early stage breast cancer.
    Rossetti S, Bshara W, Reiners JA, Corlazzoli F, Miller A, Sacchi N.
    Cancer Lett; 2016 Oct 01; 380(2):375-383. PubMed ID: 27422542
    [Abstract] [Full Text] [Related]

  • 6. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI, Sharma G, Zhao X, Mirza S, Srivastava S, Dave BJ, Aleskandarany M, Rakha E, Mohibi S, Band H, Band V.
    Breast Cancer Res; 2016 Nov 16; 18(1):113. PubMed ID: 27852327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mammary epithelial morphogenesis and early breast cancer. Evidence of involvement of basal components of the RNA Polymerase I transcription machinery.
    Rossetti S, Wierzbicki AJ, Sacchi N.
    Cell Cycle; 2016 Sep 16; 15(18):2515-26. PubMed ID: 27485818
    [Abstract] [Full Text] [Related]

  • 9. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M, Smith WP, Chien J, Herschkowitz JI, Troester MA, Beck M, Inciardi M, Gatewood J, May L, Cusick T, McGinness M, Ricci L, Fan F, Tawfik O, Marks JR, Knapp JR, Yeh HW, Thomas P, Carrasco DR, Fields TA, Godwin AK, Behbod F.
    Breast Cancer Res; 2015 Sep 17; 17():128. PubMed ID: 26384318
    [Abstract] [Full Text] [Related]

  • 10. LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling.
    Chang J, Nicolau MM, Cox TR, Wetterskog D, Martens JW, Barker HE, Erler JT.
    Breast Cancer Res; 2013 Sep 17; 15(4):R67. PubMed ID: 23971878
    [Abstract] [Full Text] [Related]

  • 11. Hypoxic conditions induce a cancer-like phenotype in human breast epithelial cells.
    Vaapil M, Helczynska K, Villadsen R, Petersen OW, Johansson E, Beckman S, Larsson C, Påhlman S, Jögi A.
    PLoS One; 2012 Sep 17; 7(9):e46543. PubMed ID: 23029547
    [Abstract] [Full Text] [Related]

  • 12. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI, Konstadoulakis MM, Vezeridis MP, Wanebo HJ.
    Ann Surg; 1995 Jun 17; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [Abstract] [Full Text] [Related]

  • 13. Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.
    Evans MF, Vacek PM, Sprague BL, Stein GS, Stein JL, Weaver DL.
    J Cell Biochem; 2020 Feb 17; 121(2):1736-1746. PubMed ID: 31595577
    [Abstract] [Full Text] [Related]

  • 14. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
    Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K.
    Breast Cancer Res; 2014 Feb 17; 16(6):3417. PubMed ID: 25551582
    [Abstract] [Full Text] [Related]

  • 15. 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.
    Neal CL, Yao J, Yang W, Zhou X, Nguyen NT, Lu J, Danes CG, Guo H, Lan KH, Ensor J, Hittelman W, Hung MC, Yu D.
    Cancer Res; 2009 Apr 15; 69(8):3425-32. PubMed ID: 19318578
    [Abstract] [Full Text] [Related]

  • 16. A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans.
    Ibrahim AM, Bilsland A, Rickelt S, Morris JS, Stein T.
    Breast Cancer Res; 2021 Sep 26; 23(1):90. PubMed ID: 34565423
    [Abstract] [Full Text] [Related]

  • 17. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F, Man YG, Bratthauer GL, Ratschek M, Tavassoli FA.
    Cancer; 2000 May 01; 88(9):2072-81. PubMed ID: 10813719
    [Abstract] [Full Text] [Related]

  • 18. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
    Yu M, Lin G, Arshadi N, Kalatskaya I, Xue B, Haider S, Nguyen F, Boutros PC, Elson A, Muthuswamy LB, Tonks NK, Muthuswamy SK.
    Mol Cell Biol; 2012 Oct 01; 32(19):3913-24. PubMed ID: 22851698
    [Abstract] [Full Text] [Related]

  • 19. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
    Liu D, Zhou K.
    Clin Breast Cancer; 2020 Feb 01; 20(1):41-50.e8. PubMed ID: 31547956
    [Abstract] [Full Text] [Related]

  • 20. Tightly controlled MRTF-A activity regulates epithelial differentiation during formation of mammary acini.
    Seifert A, Posern G.
    Breast Cancer Res; 2017 Jun 07; 19(1):68. PubMed ID: 28592291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.